TLPH Talphera, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Talphera (TLPH) Stock: Buy, Sell, or Hold?

$0.86
-0.05 (-4.98%) ▼
5d: -21.02% 30d: -20.29% 90d: -28.85%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
35/100
Position
OVERSOLD
30-Day Fair Range
$1.00 – $1.11
Position: OVERSOLD
Forward P/E & Valuation
-4.1x
Next 12M consensus est.
Wall Street Target
$3.13
+244.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.77 / $1.17
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: TLPH is down 21.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When TLPH Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: TLPH is currently trading at $0.86, which is considered oversold relative to its 30-day fair value range of $1.00 to $1.11.

Technical Outlook: Technically, TLPH is in a downtrend. Immediate support is located at $0.77, while resistance sits at $1.17. Short-term momentum is weak, with the stock down 5.0% recently.

Market Sentiment: TLPH scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.12 (+244.9%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.00 - $1.11
Company Quality Score 35/100 (SELL)
Volume Confirmation HIGH
Confidence Score 52.6%

Trading Range & Key Levels

30-Day Trading Range $1.00 - $1.11
Current vs Trading Range OVERSOLD
Support Level $0.77
Resistance Level $1.17
Current Trend Downtrend
Technical data as of Nov 13, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-5.0%)
  • BULLISH: Trading 244.9% below Wall St target ($3.12)
  • WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -4.06
Wall Street Target $3.13 (+244.9%)
Share TLPH Analysis

Share this live TLPH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (TLPH)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 16, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits user is looking forward to $TLPH's Q3 2026 report summary, expressing optimism for a resolution by the end of the year.
Key Retail Themes: Q3 2026 report Company expectations
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 16, 2026 2:11 PM ET
Data refreshes hourly during market hours. Next update: 3:11 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for TLPH.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
28 analysts
$208 30 SELL
ALKS
Alkermes Plc
STRONG BUY
20 analysts
$58 32 SELL
AQST
Aquestive Therapeutics I…
STRONG BUY
9 analysts
$9 59 HOLD
AMLX
Amylyx Pharmaceuticals I…
STRONG BUY
12 analysts
$43 52 HOLD
UTHR
United Therapeutics Corp…
STRONG BUY
15 analysts
$687 47 HOLD
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals